Parkinsons Disease

Papers
(The median citation count of Parkinsons Disease is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Protective Role of AMPK against PINK1B9 Flies’ Neurodegeneration with Improved Mitochondrial Function18
Gastrointestinal Dysfunction Impact on Life Quality in a Cohort of Russian Patients with Parkinson’s Disease I-III H&Y Stage17
The Role of Muscle Strength in the Sit-to-Stand Task in Parkinson’s Disease17
Effect of NTN and Lmx1α on the Notch Signaling Pathway during the Differentiation of Human Bone Marrow Mesenchymal Stem Cells into Dopaminergic Neuron-Like Cells15
Treatment Satisfaction and Its Influencing Factors in Parkinson’s Disease: A Web-Based Survey of Patients and Physicians in Clinical Practice in Japan12
α-Synuclein E46K Mutation and Involvement of Oxidative Stress in a Drosophila Model of Parkinson’s Disease12
Reverse Visually Guided Reaching in Patients with Parkinson’s Disease9
The Rehabilitative Effect of Archery Exercise Intervention in Patients with Parkinson’s Disease7
A Dual GLP-1/GIP Receptor Agonist Is More Effective than Liraglutide in the A53T Mouse Model of Parkinson’s Disease7
Association between Baseline Cognitive Score and Postoperative Delirium in Parkinson’s Disease Patients following Deep Brain Stimulation Surgery7
Genome- and Exome-Wide Association Studies Revealed Candidate Genes Associated with DaTscan Imaging Features6
Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease6
Exploring the Caregiver Role after Deep Brain Stimulation Surgery for Parkinson’s Disease: A Qualitative Analysis6
Transfection of the BDNF Gene in the Surviving Dopamine Neurons in Conjunction with Continuous Administration of Pramipexole Restores Normal Motor Behavior in a Bilateral Rat Model of Parkinson’s Dise6
Efficacy and Feasibility of Remote Cognitive Remediation Therapy in Parkinson’s Disease: A Randomized Controlled Trial5
Lifestyle Factors and Parkinson’s Disease Risk in a Rural New England Case-Control Study5
Impact of Gastrointestinal Symptoms on Health-Related Quality of Life in an Australian Parkinson’s Disease Cohort5
An Investigation into the Use and Meaning of Parkinson’s Disease Clinical Scale Scores5
Impact of Progression of Parkinson’s Disease on Swallowing Ability and Oral Environment5
The Current State of Parkinsonism in West Africa: A Systematic Review5
Validity and Reliability of the Persian Version of Parkinson’s Disease Sleep Scale-25
Effectiveness and Feasibility of Nonpharmacological Interventions for People With Parkinson’s Disease and Cognitive Impairment on Patient‐Centred Outcomes5
China’s Modified Version of Sniffin’ Sticks 12‐Identification Test Used in Chinese Parkinson’s Disease and Multiple System Patients: Comparison of Three Olfactory Testing Methods5
Possible Implications of Managing Alexithymia on Quality of Life in Parkinson’s Disease: A Systematic Review5
5
Progression of Nonmotor Symptoms in Parkinson’s Disease by Sex and Motor Laterality4
Evaluation of Motor Complications in Parkinson’s Disease: Understanding the Perception Gap between Patients and Physicians4
Validation of the Non-Motor Symptoms Scale for Parkinson’s Disease of Persian Version4
Movement Disorders Associated with COVID-194
Central Pain in Parkinson’s Disease: Behavioral and Cognitive Characteristics4
Gender Was Associated with Depression but Not with Gastrointestinal Dysfunction in Patients with Parkinson’s Disease4
Time until Need for Levodopa among New Users of Dopamine Agonists or MAO-B Inhibitors4
Neuroprotective Effects of Estradiol plus Lithium Chloride via Anti-Apoptosis and Neurogenesis Pathway in In Vitro and In Vivo Parkinson’s Disease Models4
The Lived Experience of Caregiving and Perception of Service Provision among Family-Caregivers of People with Late-Stage Parkinson’s: A Qualitative Study4
Identification of Potential Core Genes in Parkinson’s Disease Using Bioinformatics Analysis4
Prevalence of Fabry Disease among Patients with Parkinson’s Disease4
Lee Silverman Voice Treatment to Improve Speech in Parkinson’s Disease: A Systemic Review and Meta-Analysis3
Intestinal Transit in Early Moderate Parkinson’s Disease Correlates with Probable RBD: Subclinical Esophageal Dysmotility Does Not Correlate3
How Cognitive Reserve should Influence Rehabilitation Choices using Virtual Reality in Parkinson’s Disease3
Evaluation of Patients with Parkinson’s Disease in Intensive Care Units: A Cohort Study3
The Anti-Inflammatory Effect of Preventive Intervention with Ketogenic Diet Mediated by the Histone Acetylation of mGluR5 Promotor Region in Rat Parkinson’s Disease Model: A Dual-Tracer PET Study3
Validation of the Parkinson’s Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy3
Implications of Convolutional Neural Network for Brain MRI Image Classification to Identify Alzheimer’s Disease3
Two-Channel Portable Biopotential Recording System Can Detect REM Sleep Behavioral Disorder: Validation Study with a Comparison of Polysomnography3
Clozapine for Quetiapine‐Refractory Psychosis in Parkinson’s Disease: A Long‐Term Single‐Center Retrospective Study3
Evaluation of Brain SPECT with 99mTc-TRODAT-1 in the Differential Diagnosis of Parkinsonism3
Single-Cell Analyses Reveal Necroptosis’s Potential Role in Neuron Degeneration and Show Enhanced Neuron-Immune Cell Interaction in Parkinson’s Disease Progression3
Vulnerability of Parkinson’s Patients to COVID-19 and Its Consequences and Effects on Them: A Systematic Review3
Trait Impulsivity as a Feature of Parkinson’s Disease Treatment and Progression3
Central Aortic Pressure and Arterial Stiffness in Parkinson’s Disease: A Comparative Study2
Ultrasonographic Changes in Brain Hemodynamics in Patients with Parkinson’s Disease and Risk Factors for Cerebrovascular Disease: A Pilot Study2
Neuroprotective Effect of Intrastriatal Caffeic Acid Phenethyl Ester Treatment in 6-OH Dopamine Model of Parkinson’s Disease in Rats2
2
Confirming Parkinson Disease Diagnosis: Patterns of Diagnostic Changes by Movement Disorder Specialists2
Odor Identification by Parkinson’s Disease Patients Tested by Using Sniffin’ Sticks versus Natural Spices2
Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines2
A Cognitive‐Behavioral Model of Apathy in Parkinson’s Disease2
Daily Exercise Patterns and Their Differences between Parkinson’s Disease Patients with and without Postural Instability2
Cystatin C Secretion in Blood Derivatives and Cellular Models of Idiopathic Parkinson’s Disease2
Cinnamaldehyde Attenuates the Expression of IBA1 and GFAP to Inhibit Glial Cell Activation and Inflammation in the MPTP‐Induced Acute Parkinson’s Disease Model2
Association of p53 with Neurodegeneration in Parkinson’s Disease2
Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study1
The Relationship between Visual-Evoked Potential and Optic Coherence Tomography and Clinical Findings in Parkinson Patients1
Handgrip Strength and Anthropometry in Parkinson’s Disease at Diagnosis1
Levodopa Prescription Patterns in Patients with Advanced Parkinson’s Disease: A Japanese Database Analysis1
Alprazolam Reduces Freezing of Gait (FOG) and Improves FOG-Related Gait Deficiencies1
Cognitive Impairment in Genetic Parkinson’s Disease1
Apathy following Bilateral Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus Internus in Parkinson’s Disease: A Meta-Analysis1
GuitarPD: A Randomized Pilot Study on the Impact of Nontraditional Guitar Instruction on Functional Movement and Well-Being in Parkinson’s Disease1
Validation of the Japanese Version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease-Rating Scale (QUIP-RS)1
Use of a Smartphone to Gather Parkinson’s Disease Neurological Vital Signs during the COVID-19 Pandemic1
Dyrk1a Phosphorylation of α-Synuclein Mediating Apoptosis of Dopaminergic Neurons in Parkinson’s Disease1
Dance Is an Accessible Physical Activity for People with Parkinson’s Disease1
Association of Specific Leg Muscle Strength and Motor Features in Parkinson’s Disease1
Mental Fatigue in Parkinson’s Disease: Systematic Review and Evaluation of Self‐Reported Fatigue Scales1
Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group1
Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search1
Qualitative Analysis of Attitudes, Knowledge, and Interest in Research of People with Parkinson’s Disease and Their Care Partners Receiving Accessible Research Education1
Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease1
Compliance with National and International Guidelines in the Treatment of Nonmotor Symptoms in Late-Stage Parkinson’s Disease1
Supplementary Motor Area Activity Differs in Parkinson’s Disease with and without Freezing of Gait1
Rasagiline as Adjunct to Levodopa for Treatment of Parkinson’s Disease: A Systematic Review and Meta-Analysis1
Transcranial Sonography of the Substantia Nigra for the Differential Diagnosis of Parkinson’s Disease and Other Movement Disorders: A Meta-Analysis1
Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson’s Disease1
Collective Expert Perspectives on the Use of Safinamide as Adjunctive Therapy for Parkinson’s Disease: Online-Based Delphi Survey1
Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson’s Disease1
Effects of an Aquatic Physical Exercise Program on Ventilatory Parameters in People with Parkinson’s Disease1
Altered Regional Homogeneity and Functional Connectivity during Microlesion Period after Deep Brain Stimulation in Parkinson’s Disease1
Evaluating Oculomotor Tests before and after Vestibular Rehabilitation in Patients with Parkinson’s Disease: A Pilot Pre-Post Study1
A Mixed Methods Approach to Explore the Experience of Pain and Its Management in People with Parkinson’s Disease1
Sex Differences in the Allele Distribution of PGLYRP2 Variant rs892145 in Parkinson’s Disease1
Impact of Off-Time on Quality of Life in Parkinson’s Patients and Their Caregivers: Insights from Social Media1
Oxidative Stress: A New Pathophysiological Pathway in Parkinson’s Disease and a Potential Target of the Brain‐Sport Crosstalk1
0.044770002365112